Dr. Houman Farzin is a staff physician at the palliative care and family medicine departments of the Jewish General Hospital in Montreal. He is a lecturer at McGill University medical school, where he earned his medical degree and completed his residency training.
He has a broad range of clinical skills and has spent many years working in remote communities across North America, including the Arctic Circle. He is passionate about the health and wellbeing of the indigenous and immigrant populations and hopes to expand access to care in these communities.
More recently he has been focusing on the applied sciences of psychedelic-assisted therapies for mental health, life-threatening illness, and end-of-life care. He holds an M.Sc. in Nutrition from Columbia University and a B.A. in Molecular & Cell Biology from the University of California Berkeley. He is also trained in ketamine-assisted psychotherapy and psilocybin-assisted psychotherapy.
Dr. Farzin is the Montreal site physician for the Phase 3 clinical trial of the MDMA-assisted therapy sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) and has also completed the MDMA therapist training program. In his spare time, he enjoys nature, makes music, and performs as a disc jockey.